The global forage feed market has been undergoing noteworthy development in the past few years. This can be accredited to the progression in farm animal production, upsurge in the global meat intake, and growing awareness regar…
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational
drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and
its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economic
weakness and negative demographic trends will limit growth prospects.
Headline Expenditure Projections
? Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.7% in
local currency terms and 3.8% in US dollar terms. Forecast unchanged from previous quarter.
? Healthcare: MDL12.32bn (USD654mn) in 2015 to MDL13.27bn (USD686mn) in 2015; +7.7% in local
currency terms and 4.8% in US dollar terms. Forecast unchanged from previous quarter.